A high calorie diet causes memory loss, metabolic syndrome and oxidative stress into hippocampus and temporal cortex of rats

Synapse

Volumn 69, Issue 9, 2015, Pages 421-433

  Treviño, Samuel ^a   Aguilar Alonso, Patrícia ^a   Flores Hernandez, Jose Angel ^a   Brambila, Eduardo ^a   Guevara, Jorge ^b   Flores, Gonzalo ^a   Lopez Lopez, Gustavo ^a   Muñoz Arenas, Guadalupe ^a   Morales Medina, Julio Cesar ^c   Toxqui, Veronica ^a,d   Venegas, Berenice ^a   Diaz, Alfonso ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c CENTRO TLAXCALA DE BIOLOGÍA DE LA CONDUCTA   (Mexico)

^d NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Astrocytes; High caloric diet; Hippocampus; Metabolic syndrome; Neurodegeneration; Reactive oxygen species

Indexed keywords

INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; GLIAL FIBRILLARY ACIDIC PROTEIN; IL1B PROTEIN, RAT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CALORIC INTAKE; CONTROLLED STUDY; ENERGY METABOLISM; HIPPOCAMPUS; INFLAMMATION; LIPID PEROXIDATION; MALE; MEMORY DISORDER; METABOLIC SYNDROME X; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TEMPORAL CORTEX; ADVERSE EFFECTS; ANIMAL; DEGENERATIVE DISEASE; DIET; IMMUNOMODULATION; MEMORY DISORDERS; METABOLIC DISEASES; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPATIAL LEARNING; TEMPORAL LOBE; WISTAR RAT;

ANIMALS; ASTROCYTES; DIET; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INTERLEUKIN-1BETA; LIPID PEROXIDATION; MALE; MEMORY DISORDERS; METABOLIC DISEASES; NEURODEGENERATIVE DISEASES; NEUROIMMUNOMODULATION; OXIDATIVE STRESS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SPATIAL LEARNING; SPATIAL MEMORY; TEMPORAL LOBE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84937735593     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21832     Document Type: Article

References (76)

1. Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB. 2011. Diabetes mellitus and Alzheimer's disease: Shared pathology and treatment? Br J Clin Pharmacol 71:365-376.
2. Ali SF, David SN, Newport GD. 1993. Age-related susceptibility to MPTP-induced neurotoxicity in mice Neurotoxicology 14:29-34.
3. Benveniste EN. 1992. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am J Physiol 263:1-16.
4. Biessels GJ, Deary IJ, Ryan CM. 2008. Cognition and diabetes: A lifespan perspective. Lancet Neurol 7:184-190.
5. Bishop NA, Lu T, Yankner BA. 2010. Neural mechanisms of ageing and cognitive decline. Nature 464:529-535.
6. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M. 2005. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci 9:381-393.
7. Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B. 2012. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res 9:5-17.
8. Catalani A, Sabbatini M, Consoli C, Cinque C, Tomassoni D, Azmitia E, Angelucci L, Amenta F. 2002. Glial fibrillary acidic protein immunoreactive astrocytes in developing rat hippocampus. Mech Ageing Dev 123:481-490.
9. Cheung WM, Wang CK, Kuo JS, Lin TN. 1999. Changes in the level of glial fibrillary acidic protein (GFAP) after mild and severe focal cerebral ischemia. Chin J Physiol 42:227-235.
10. Chiu SL. 2008. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58:708-719.
11. Diaz A, Mendieta L, Zenteno E, Guevara J, Limon ID. 2011. The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 25-35 into the temporal cortex. Pharmacol Biochem Behav 98:67-75.
12. Diaz A, Limon D, Chávez R, Zenteno E, Guevara J. 2012. Aβ25-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats. J Alzheimers Dis 30:505-522.
13. Díaz A, Rojas K, Espinosa B, Chávez R, Zenteno E, Limón D, Guevara J. 2014. Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25-35 injection in rats. Neuropeptides 48:153-159.
14. Eikelenboom P, van Gool WA. 2004. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm 111:281-294.
15. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O. 2006. Obesity and risk for chronic renal failure. J Am Soc Nephrol 17:1695-1702.
16. Etgen T, Sander D, Bickel H, Förstl H. 2011. Mild cognitive impairment and dementia: The importance of modifiable risk factors. Dtsch Arztebl Int 108:743-750.
17. Farr SA, Yamada KA, Butterfield DA Abdul HM, Xu L, Miller NE, Banks WA Morley JE. 2008. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149:2628-2636.
18. Ford ES, Bergmann MM, Boeing H, Li C, Capewell S. 2012. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med 55:23-27.
19. Freeman LR, Haley-Zitlin V, Stevens C, Granholm AC. 2011. Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus. Nutr Neurosci 14:32-44.
20. Garcia JH, Liu KF, Ho KL. 1995. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progress at different time intervals in the caudoputamen and the cortex. Stroke 26:636-642.
21. Golden TR, Melov S. 2001. Mitochondrial DNA mutations, oxidative stress, and aging. Mech Ageing Dev 122:1577-1589.
22. Gosselet F, Saint-Pol J, Candela P, Fenart L. 2013. Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier. Curr Alzheimer Res 10:1015-1033.
23. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
24. Heber D. 2010. An integrative view of obesity. Am J Clin Nutr 91:280S-283S.
25. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444:860-867.
26. Jeon KP, Jeong TY, Lee SY, Hwang SW, Shin JH, Kim DS. 2012. Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy. Korean J Urol 53:593-597.
27. Jin W, Wang H, Yan W, Xu L, Wang X, Zhao X, Yang X, Chen G, Ji Y. 2008. Disruption of Nrf2 enhances upregulation of nuclear factor-kappa B activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008:1:7.
28. Kanoski SE Meisel RL, Mullins AJ Davidson TL. 2007. The effects of energy-rich diets on discrimination reversal learning and on BDNF in the hippocampus and prefrontal cortex of the rat. Behav Brain Res 182:57-66.
29. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. 2011. Metabolic syndrome: definitions and controversies. BMC Med 9:48-53.
30. Kiyota Y, Miyamoto M, Nagaoka A. 1991. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain Res 538:295-302.
31. Kressel G, Trunz B, Bub A, Hülsmann O, Wolters M, Lichtinghagen R, Stichtenoth DO, Hahn A. 2009. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis 202:263-271.
32. Lee H, Pienaar IS. 2014. Disruption of the blood-brain barrier in Parkinson's disease: Curse or route to a cure? Front Biosci (Landmark Ed) 19:272-280.
33. Liese AD, Hense HW, Döring A, Stieber J, Keil U. 2001. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 15:799-804.
34. Limón D, Díaz A, Hernandez M, Fernandez-G JM, Torres-Martínez AC, Pérez-Severiano F, Rendón-Huerta EP, Montaño LF, Guevara J. 2012. Neuroprotective effect of the aminoestrogen prolame against impairment of learning and memory skills in rats injected with amyloid-β-25-35 into the hippocampus. Eur J Pharmacol 685:74-80.
35. Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. 2012. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 26:101-105.
36. Lue LF, Andrade C, Sabbagh M, Walker D. 2012. Is There Inflammatory synergy in Type II diabetes mellitus and Alzheimer's disease? Int J Alzheimers Dis 2012:918680.
37. Luque-Contreras D, Carvajal K, Toral-Rios D, Franco-Bocanegra D, Campos-Peña V. 2014. Oxidative stress and metabolic syndrome: Cause or consequence of Alzheimer's disease? Oxid Med Cell Longev 2014:497802.
38. Martinez-Tellez R, Gómez-Villalobos MJ, Flores G. 2005. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 1048:108-115.
39. Mauro C, De Rosa V, Marelli-Berg F, Solito E. 2015. Metabolic syndrome and the immunological affair with the blood-brain barrier. Front Immunol 5:677.
40. Mc Geer PL, Schulzer M, McGeer EG. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of epidemiologic studies. Neurology 47:425-432.
41. Meda L, Baron P, Scarlato G. 2001. Glial activation in Alzheimer's disease: The role of Abeta and its associated proteins. Neurobiol Aging 22:885-893.
42. Metlakunta AS. 2008. Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology 149:1121-1128.
43. Mielke JG, Wang YT. 2011. Insulin, synaptic function, and opportunities for neuroprotection. Prog Mol Biol Transl Sci 98:133-186.
44. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13-23.
45. Miossec P. 2009. IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 11:625-630.
46. Moncada S, Bolanos JP. 2006. Nitric oxide cell bioenergetics and neurodegeneration. J Neurochem 97:1676-1689.
47. Morris R. 1984. Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
48. Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. 2014. Diabetes and the brain: Oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev 2014:102158.
49. Mushtaq G, Khan JA, Kumosani TA, Kamal MA. 2015. Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci 22:4-13.
50. Obrosova IG. 2007. High-fat diet induced neuropathy of pre-diabetes and obesity: Effects of "healthy" diet and aldose reductase inhibition. Diabetes 56:2598-2608.
51. Ouyang S, Hsuchou H, Kastin AJ, Wang Y, Yu C, Pan W. 2014. Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier. J Cereb Blood Flow Metab 34:43-51.
52. Parrott MD, Greenwood CE. 2007. Dietary influences on cognitive function with aging: From high-fat diets to healthful eating. Ann NY Acad Sci 1114:389-397.
53. Pasinetti GM, Eberstein JA. 2008. Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem 106:1503-1514.
54. Pérez-Severiano F, Rodríguez-Pérez M, Pedraza-Chaverrí J, Maldonado PD, Medina-Campos ON, Ortíz-Plata A, Sánchez-García A, Villeda-Hernández J, Galván-Arzate S, Aguilera P, Santamaría A. 2004. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int 45:1175-1183.
55. Potteiger JA, Jacobsen DJ Donnelly JE. 2002. A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults. Int J Obes Relat Metab Disord 26:87-89.
56. Purkayastha S, Cai D. 2013. Neuroinflammatory basis of metabolic syndrome. Mol Metab 2:356-363.
57. Purves RD. 1992. Bias and variance of extrapolated tails for area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J Pharmacokinet Biopharm 20:501-510.
58. Reaven GM. 2011. The metabolic syndrome: time to get off the merry-go-round?. J Intern Med 269:127-136.
59. Rodrigo J, Fernandez Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, Gomez Isla T, Martinez-Murillo R, Martinez A, Serrano J, Fernandez AP. 2004. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Neuroscience 128:73-89.
60. Rogers P, Webb GP. 1980. Estimation of body fat in normal and obese mice. Br J Nutr 43:83-86.
61. Sanchez-Vega L, Juárez I, De Jesus Gomez-Villalobos M, Flores G. 2015. Cerebrolysin reverses hippocampal neural atrophy in a mice model of diabetes mellitus type 1. Synapse 69:326-335.
62. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025.
63. Sriram K, Benkovic SA, Miller DB, O'Callaghan JP. 2002. Obesity exacerbates chemically induced neurodegeneration. Neuroscience 115:1335-1346.
64. Stapleton HM, Kelly SM, Allen JG, Mcclean MD, Webster TF. 2008. Measurement of polybrominated diphenyl ethers on hand wipes: estimating exposure from hand-to-mouth contact. Environ Sci Technol 42:3329-3334.
65. Stranahan A, Egan J, Norman E, Lee K, Mattson P. 2008. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18:1085-1088.
66. Tomassoni D, Nwankwo IE, Gabrielli MG, Bhatt S, Muhammad AB, Lokhandwala MF, Tayebati SK, Amenta F. 2013. Astrogliosis in the brain of obese Zucker rat: A model of metabolic syndrome. Neurosci Lett 543:136-141.
67. Tucsek Z, Toth P, Sosnowska D, Gautam T, Mitschelen M, Koller A, Szalai G, Sonntag WE, Ungvari Z, Csiszar A. 2014. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: Effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. J Gerontol A: Biol Sci Med Sci 69:1212-1226.
68. Tuppo EE, Arias HR. 2005. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 37:289-305.
69. Van der Heide LP. 2005. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinasedependent manner. Neurochem 94:1158-1166.
70. Veerhuis R, Boshuizen RS, Familian A. 2005. Amyloid asso- ciated proteins in Alzheimer's and prion disease. Curr Drug Targets CNS Neurol Disord 4:235-248.
71. Whitmer RA. 2007. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 27:373-380.
72. Winzell MS, Ahren B. 2004. The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53:S215-S219.
73. Wrighten SA, Piroli GG, Grillo CA, Reagan LP. 2009. A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Acta 1792:444-453.
74. Wu A, Ying Z, Gomez-Pinilla F. 2004. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 19:1699-1707.
75. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. 2012. Impact of metabolic syndrome on cognition and brain: A selected review of the literature. Arterioscler Thromb Vasc Biol 32:2060-2067.
76. Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. 2005. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol 191:318-325.